Prescription drug · ANDA
Clobetasol Propionate NDC 70752-153
Clobetasol propionate .5 mg/mL · Solution · Topical · Quagen Pharmaceuticals LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 70752-153-04 | 70752015304 | 1 BOTTLE in 1 CARTON (70752-153-04) / 50 mL in 1 BOTTLEMarketed from Mar 14, 2022 | |
| 70752-153-20 | 70752015320 | 1 BOTTLE in 1 CARTON (70752-153-20) / 25 mL in 1 BOTTLEMarketed from Mar 14, 2022 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Clobetasol Propionate
- Generic name (nonproprietary)
- clobetasol propionate
- Active ingredients
- Clobetasol propionate — .5 mg/mL
- Dosage form
- Solution
- Route
- Topical
- Labeler
- Quagen Pharmaceuticals LLC
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 211240
- Marketing start
- Listing expires
- Other FDA classes
- Corticosteroid Hormone Receptor Agonists (Mechanism)
- Identifiers
- Product ID 70752-153_b21464f4-6d72-4ecb-a3a8-5478fdd22affSPL ID b21464f4-6d72-4ecb-a3a8-5478fdd22affSPL set ID 5f6d2a57-92c9-4568-83d1-524de42182b4RxCUI 861487UNII 779619577M
- Pharmacologic class
- Corticosteroid
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N470752015304followed by a unit qualifier and the quantityPackage 70752-0153-04. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Clobetasol propionate topical solution is indicated for short-term topical treatment of inflammatory and pruritic manifestations of moderate to severe corticosteroid-responsive dermatoses of the scalp. Treatment beyond 2 consecutive weeks is not recommended, and the total dosage should not exceed 50 mL/week because of the potential for the drug to suppress the HPA axis. This product is not recommended for use in pediatric patients under 12 years of age.
Excerpt only. Read the full label for complete information.